Guaifenesin 69848-0017-02
- Manufacturer
- Granules Usa, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- December 31, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA213420
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Selected Package
69848-0017-02Selected20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (69848-017-02)